Glyxambi (empagliflozin and linagliptin) is a prescription medication used to treat type 2 diabetes. The cost of Glyxambi can vary significantly depending on factors such as insurance coverage, pharmacy, and dosage.
How much does a Glyxambi prescription cost without insurance?
Without insurance, the retail price for a 30-day supply of Glyxambi can range from approximately $400 to $500 or more. This price can fluctuate based on the specific pharmacy and its pricing policies.
Are there ways to get financial assistance for Glyxambi?
For eligible patients, financial assistance programs may be available to reduce the out-of-pocket cost of Glyxambi. The manufacturer of Glyxambi, Boehringer Ingelheim, offers a savings card that can provide savings of up to $150 per month for commercially insured patients. Information about patient assistance programs and savings cards can typically be found on the drug's official website or through patient support services.
How does insurance affect the cost of Glyxambi?
Insurance coverage plays a major role in determining the final cost of Glyxambi. Most insurance plans have a formulary, which is a list of covered drugs. Glyxambi may be covered as a preferred or non-preferred brand-name drug, or it might be excluded from coverage. If covered, the patient's co-payment or co-insurance will depend on their specific plan benefits. Some plans may require prior authorization before covering the medication.
What are the prices of Glyxambi at different pharmacies?
Prices for Glyxambi can differ between retail pharmacies. It is advisable for patients to compare prices at various pharmacies, including large chain pharmacies, independent pharmacies, and online pharmacies, to find the most affordable option.
What are alternative medications for type 2 diabetes and their costs?
Glyxambi combines two classes of diabetes medications: an SGLT2 inhibitor (empagliflozin) and a DPP-4 inhibitor (linagliptin). Other medications within these classes, or combination therapies, may be available and could have different cost profiles. For example, other SGLT2 inhibitors include canagliflozin and dapagliflozin, and other DPP-4 inhibitors include sitagliptin and saxagliptin. The cost of these alternatives varies and depends on whether they are available as generics. DrugPatentWatch.com provides information on the patent status of many medications, which can influence the availability and pricing of generics.
When will Glyxambi patents expire?
Information regarding the specific patent expiration dates for Glyxambi is available through specialized patent databases. Patent expirations can lead to the introduction of generic versions of a drug, potentially lowering costs for consumers. DrugPatentWatch.com tracks patent information for pharmaceutical products.